
Warren Hern's former staff reopens 'all-trimester' abortion facility in Colorado
Cassy Cooke
·We are urgently seeking 500 new Life Defenders (monthly supporters) before the end of October to help save babies from abortion 365 days a year. Your first gift as a Life Defender today will be DOUBLED. Click here to make your monthly commitment.
Abortion Pill·By Nancy Flanders
Attorneys general ask FDA to reverse decision on abortion pill
On Friday, attorneys general from 22 different states signed a letter to the Federal Drug Administration (FDA), requesting that it reverse its recent decision to expand access to the abortion pill through direct pharmacy distribution.
In the letter to FDA Commissioner Dr. Robert Califf, attorneys general from states including Alabama, Florida, Georgia, and Kentucky, urged a reversal. “The Food and Drug Administration’s decision to abandon commonsense restrictions on remotely prescribing and administering abortion-inducing drugs is both illegal and dangerous,” the letter reads. “In direct contravention of longstanding FDA practice and congressional mandate, the FDA’s rollback of important safety restrictions ignores both women’s health and straightforward federal statutes. We urge you to reverse your decision.”
Earlier this month, Danco Laboratories, the U.S. manufacturer of the abortion pill, announced that pharmacies can now become certified to dispense Mifeprex® (mifepristone) — the first drug in the abortion pill regimen — directly to patients. Prior to this, women were required to obtain mifepristone from a licensed clinic or medical facility, but are no longer required to do so despite the fact that studies have shown the abortion pill to be four times more dangerous than a first-trimester surgical abortion.
“Pharmacies who become certified in the Mifepristone REMS Program may dispense Mifeprex® directly to patients upon receipt of a prescription from a certified Mifeprex® prescriber, provided a Prescriber agreement is provided or on file with the certified pharmacy,” Danco’s press release states.
Dear Reader,
Every day in America, more than 2,800 preborn babies lose their lives to abortion.
That number should break our hearts and move us to action.
Ending this tragedy requires daily commitment from people like you who refuse to stay silent.
Millions read Live Action News each month — imagine the impact if each of us took a stand for life 365 days a year.
Right now, we’re urgently seeking 500 new Life Defenders (monthly donors) to join us before the end of October. And thanks to a generous $250,000 matching grant, your first monthly gift will be DOUBLED to help save lives and build a culture that protects the preborn.
Will you become one of the 500 today? Click here now to become a Live Action Life Defender and have your first gift doubled.
Together, we can end abortion and create a future where every child is cherished and every mother is supported.
REMS is a safety requirement put in place by the FDA to monitor a small number of drugs that carry specific safety concerns. Mifepristone is one of those drugs because it carries potentially serious risks, including hemorrhaging, incomplete abortion, infection, and death.
The dangers of the abortion pill are mostly kept quiet by abortion advocates, however, the FDA’s website states, “As of June 30, 2022, there were 28 reports of deaths in patients associated with mifepristone since the product was approved in September 2000, including two cases of ectopic pregnancy (a pregnancy located outside the womb, such as in the fallopian tubes) resulting in death; and several fatal cases of severe systemic infection (also called sepsis).”*
Dr. Christina Francis, OBGYN and CEO-elect of the American Association of Pro-Life OBGYNs and Gynecologists (AAPLOG) spoke out against the FDA’s decision, saying, “The FDA, in allowing pharmacies to dispense this medication, is just, once again, showing their disregard for the safety of women, and our concern is they are moving more towards making these available potentially without a prescription.”
According to the Daily Caller, the AGs who signed the letter said that the FDA’s decision to allow pharmacies to dispense the abortion pill will not prevent pro-life states from enforcing laws to protect preborn children from abortion, including laws regarding the abortion pill.
Live Action News is pro-life news and commentary from a pro-life perspective.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Cassy Cooke
·Abortion Pill
Carole Novielli
·Abortion Pill
Carole Novielli
·Abortion Pill
Carole Novielli
·Abortion Pill
Carole Novielli
·Abortion Pill
Bridget Sielicki
·International
Nancy Flanders
·Analysis
Nancy Flanders
·Politics
Nancy Flanders
·Politics
Nancy Flanders
·Analysis
Nancy Flanders
·